January 14: Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public.

General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.

This initiative comes in response to the Prime Minister's directive to mobilize resources and enhance trade activities. The Ministry for Industry and Commerce has also entered into an agreement to support the commercial sustainability and capacity building of NDL.

Historically, the company has produced 146 types of medicines, but over time, the variety declined to nine, and currently, it only manufactures CETAMOL. In an effort to revitalize the company, there is an emphasis on investment and diversification of production.

Despite facing challenges in market competition and technological limitations, General Manager Paneru is optimistic. He believes that following the Prime Minister's guidance and implementing a robust work plan will help the company compete effectively. Paneru stressed the need for capacity building to expand production capabilities.

Assuring the quality of medicines, Paneru mentioned that the drugs would be sold and distributed in collaboration with all local levels across the country. The company has witnessed an increase in production and sales, achieving a notable milestone of selling drugs worth Rs 10.5 million in the previous month alone.

NDL Chairperson Yagya Prasad Neupane shared the company's objective to produce 98 types of drugs for government distribution. Additionally, the company plans to leverage its land for income generation, intending to establish a commercial medical hub and expand production capacity to enhance competitiveness in the pharmaceutical industry.

According to the Trade and Export Promotion Centre, the import of medicine-related products amounted to Rs 16.80 billion in the first five months of the current fiscal year (2080/81). (RSS)